Venetoclax combined with escalating doses of homoharringtonine, low-dose cytarabine, and granulocyte colony-stimulating factor demonstrates feasibility and tolerability for remission induction in pediatric acute myeloid leukemia.

IF 7.9 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-09-01 Epub Date: 2025-03-06 DOI:10.3324/haematol.2024.286832

Shengqin Cheng, Li Gao, Jun Lu, Yixin Hu, Yi Wang, Hailong He, Jie Li, Suxiang Liu, Feiyun Yang, Xiaofang Wu, Liyan Fan, Junjie Fan, Yanhua Yao, Yina Sun, Bohan Li, Yongping Zhang, Shuiyan Wu, Cheng Cheng, Peifang Xiao, Raul C Ribeiro, Hu Shaoyan

引用次数: 0

Abstract Image

查看原文本刊更多论文

Venetoclax联合高剂量的高叉杉碱、低剂量阿糖胞苷和粒细胞集落刺激因子用于儿童急性髓性白血病缓解诱导的可行性和耐受性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.